Published in Circulation on January 25, 2000
Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochem J (2003) 0.82
The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol (2008) 0.77
Antithrombotic effects of flavonoid. Circulation (2001) 0.75
Anticoagulant effect and safety assessment of an aqueous extract of Pseudocedrela kotschyi (Schweinf.) harms and Adenia cissampeloides (Planch. Ex Hook.) harms. J Intercult Ethnopharmacol (2016) 0.75
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J (2000) 2.45
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res (2000) 2.26
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet (1985) 1.95
Cardiovascular disease in women. Circulation (1993) 1.87
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J (2001) 1.72
Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg (2001) 1.70
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Clin Pharmacol Ther (2007) 1.67
Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry. J Vasc Surg (1998) 1.66
Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg (2000) 1.64
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation (1990) 1.57
Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg (1996) 1.55
Some risk factors associated with cataract in S.E. Scotland: a pilot study. Trans Ophthalmol Soc U K (1982) 1.55
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med (2000) 1.48
Refractory prinzmetal angina treated with cyproheptadine. Ann Intern Med (1994) 1.48
Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment. J Am Coll Cardiol (1993) 1.48
Four years of respiratory intensive care. Br Med J (1967) 1.47
The syndrome of spontaneous iliac arteriovenous fistula: a distinct clinical and pathophysiologic entity. Surgery (1986) 1.46
Echocardiographic determination of left ventricular dimensions, volumes and performance. Am J Cardiol (1972) 1.46
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc (1999) 1.46
Indirect revascularization of the lower extremity by means of microvascular free-muscle flap--a preliminary report. J Vasc Surg (1990) 1.45
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
Decreasing mortality with primary percutaneous coronary intervention in patients with acute myocardial infarction: the Mayo Clinic experience from 1991 through 1997. Mayo Clin Proc (2000) 1.41
Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Eur Heart J (2001) 1.41
Predictors of smoking cessation after percutaneous coronary revascularization. Mayo Clin Proc (1998) 1.41
Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med (2000) 1.41
[Effect of using icodextrin as a starting therapy for peritoneal permeability]. Nefrologia (2009) 1.40
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
[Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents]. Med Clin (Barc) (1997) 1.39
[Improvement in the treatment of acute myocardial infarct by the establishment of a thrombolysis unit in a cardiology servic]. Rev Esp Cardiol (1998) 1.39
Simultaneous inflation of tandem (sequential) angioplasty balloons: a means of simultaneously treating multiple lesions in one coronary artery. Cathet Cardiovasc Diagn (1995) 1.39
Clinical, angiographic, and procedural correlates of abrupt vascular closure during coronary intervention: a 10-year experience at Mayo Clinic. Catheter Cardiovasc Interv (1999) 1.39
Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indications. Cathet Cardiovasc Diagn (1997) 1.39
Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women. Mayo Clin Proc (1997) 1.39
[Clinical manifestations of familial hypercholesterolemia in Mediterranean population]. Med Clin (Barc) (1999) 1.38
[Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy]. Nefrologia (2011) 1.38
Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med (1997) 1.38
Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis (2007) 1.35
Ex vivo biomechanical behavior of abdominal aortic aneurysm: assessment using a new mathematical model. Ann Biomed Eng (1997) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
Reflected ultrasound in the detection and localization of pleural effusion. JAMA (1967) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Epidemiological and other studies in the assessment of factors contributing to cataractogenesis. Ciba Found Symp (1984) 1.34
Scattering of ultrasound by blood. IEEE Trans Biomed Eng (1976) 1.32
Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Clin Trials (2006) 1.31
Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg (2001) 1.31
Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg (1999) 1.28
Mechanical properties and microstructure of intraluminal thrombus from abdominal aortic aneurysm. J Biomech Eng (2001) 1.28
Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol (1997) 1.28
Complete congenital heart block. Report of 35 cases. Br Heart J (1982) 1.27
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med (2001) 1.24
Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med (1997) 1.23
Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol (1995) 1.22
Complete occlusion of the left main coronary artery and the importance of coronary collateral circulation. Mayo Clin Proc (1977) 1.22
Quantitation of carotid stenosis with continuous-wave (C-W) Doppler ultrasound. Stroke (1979) 1.21
Analysis of individual cataract patients and their lenses: a progress report. Exp Eye Res (1980) 1.21
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation (1986) 1.21
Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer. Clin Cancer Res (1997) 1.19
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol (1985) 1.18
Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol (1995) 1.18
Respiratory acidosis in hypothermic myxoedema coma. Postgrad Med J (1967) 1.17
Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg (1997) 1.17
Rheumatic mitral stenosis in association with parital anomalous pulmonary venous return. Thorax (1968) 1.17
Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis (1986) 1.15
The use of expanded microporous polytetrafluoroethylene for limb salvage: a preliminary report. Surgery (1976) 1.13
Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol (2000) 1.12
In vivo three-dimensional surface geometry of abdominal aortic aneurysms. Ann Biomed Eng (1999) 1.12
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation (1994) 1.12
Long-term follow-up of mitral valve replacement with Starr-Edwards prosthesis. Br Heart J (1972) 1.12
Respiratory intensive care: a 10-year survey. Br Med J (1974) 1.11
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation (1989) 1.11
Causes of stroke in carotid endarterectomy. Surgery (1982) 1.10
Use of non-Rayleigh statistics for the identification of tumors in ultrasonic B-scans of the breast. IEEE Trans Med Imaging (1993) 1.10
Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care (1992) 1.09
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
Pregnancy and mitral valve prosthesis. Br Med J (1971) 1.09
Utility of clinical pathway and prospective case management to achieve cost and hospital stay reduction for aortic aneurysm surgery at a tertiary care hospital. J Vasc Surg (1997) 1.09
Comparative studies of pulsatile and nonpulsatile flow during cardiopulmonary bypass. II. The effects on adrenal secretion of cortisol. J Thorac Cardiovasc Surg (1978) 1.08
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08
Interactive effects of environmental stress and inbreeding on reproductive traits in a wild bird population. J Anim Ecol (2006) 1.08
Coronary atherosclerosis. A multifactorial disease. Circulation (1993) 1.08
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis (2000) 1.08
On the inheritance of abdominal aortic aneurysm. Am J Hum Genet (1991) 1.07
Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation (1987) 1.07
Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med (2007) 1.07
Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol (1985) 1.07